Cancer
Conditions
Interventions
Healthy voluteers and patients treated by TS-1 are included in this study.
Sponsors
Furihata Kenichi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Cancer patients must meet 1)-4) and Healthy volunteer must be meet 1)-2) and 5). 1) Voluntary written informed consent to participation in the study. 2) Women aged 20 to 75 years at the time of informed consent. 3) Patients who started TS-1 treatment within 6 months. 4) Patients who have pigmentation at face. 5) Healthy volunteer whose age is +-10 compared to cancer patients.
Exclusion criteria
Exclusion criteria: 1) Patients who use moisturizer within 12 hours before sampling day. 2) Patients with skin disease wihout pigmentation at sampling area. 3) Patients with other severe diseases without cancer. 4) Patients who are strongly exposed to ultraviolet light. 5) Any conditions judged by the investigator or subinvestigator to be unsuitable for participation in the study. 1) Subjects with disease such as skin disease. 2) Subjects who use medicine within 1 week before sampling day. 3) Subjects who use moisturizer within 12 hours before sampling day. 4) Subjects who are strongly exposed to ultraviolet light. 5) Any conditions judged by the investigator or subinvestigator to be unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gene and protein expression analyses | — |
Contacts
Public Contactcontact Clinical trial information
Kyowa Kirin Co., Ltd.
Outcome results
None listed